Astrana Health (ASTH) CMO surrenders shares for equity tax withholding

Rhea-AI Filing Summary

Astrana Health, Inc. Chief Medical Officer Dinesh M. Kumar reported a tax-withholding disposition of company stock. On March 5, 2026, 1,697 shares of common stock were surrendered at $25.07 per share to cover tax obligations related to vested restricted stock units.

After this withholding transaction, Kumar directly held 200,335 shares of Astrana Health common stock. This total includes time-based and performance-based restricted stock and restricted stock units that will vest over future dates, as well as 1,405 shares previously acquired under the employee stock purchase plan.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Kumar Dinesh M.

Role Chief Medical Officer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock	1,697	$25.07	$43K

Holdings After Transaction: Common Stock — 200,335 shares (Direct)

Footnotes (1)

1. Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on March 5, 2026. Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 28,378 shares, which will vest on January 23, 2027; and (ii) grants of 8,158 shares and 3,264 shares, each of which will vest subject to the achievement of certain performance goals. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 67,238 restricted stock units, which will vest subject to the achievement of certain performance goals; and (ii) 20,027 restricted stock units, which will vest in six equal semi-annual installments beginning on September 5, 2026. Includes 1,405 shares acquired under the Issuer's Employee Stock Purchase Plan.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kumar Dinesh M.

(Last) (First) (Middle)

C/O ASTRANA HEALTH, INC.

1668 S. GARFIELD AVENUE, 2ND FLOOR

(Street)

ALHAMBRA CA 91801

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Astrana Health, Inc. [ ASTH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Medical Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/05/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/05/2026		F		1,697(1)	D	$25.07	200,335(2)(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents the surrender of shares to offset against tax withholding obligations associated with certain restricted stock units that vested on March 5, 2026.

2. Includes the following shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 28,378 shares, which will vest on January 23, 2027; and (ii) grants of 8,158 shares and 3,264 shares, each of which will vest subject to the achievement of certain performance goals. Also includes the following restricted stock units, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 67,238 restricted stock units, which will vest subject to the achievement of certain performance goals; and (ii) 20,027 restricted stock units, which will vest in six equal semi-annual installments beginning on September 5, 2026.

3. Includes 1,405 shares acquired under the Issuer's Employee Stock Purchase Plan.

	/s/ Kathy Diep, as Attorney-in-Fact	03/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Astrana Health (ASTH) disclose for Dinesh M. Kumar?

Astrana Health disclosed that Chief Medical Officer Dinesh M. Kumar surrendered shares in a tax-withholding disposition. On March 5, 2026, 1,697 common shares were withheld to satisfy tax obligations arising from the vesting of restricted stock units, rather than being sold in the open market.

How many Astrana Health (ASTH) shares were disposed of and at what price?

Kumar had 1,697 shares of Astrana Health common stock surrendered for taxes at $25.07 per share. This transaction was coded as a tax-withholding disposition, meaning the shares were used to cover tax liabilities tied to vesting equity awards instead of a discretionary sale.

How many Astrana Health (ASTH) shares does Dinesh M. Kumar hold after this transaction?

Following the tax-withholding disposition, Kumar directly held 200,335 Astrana Health shares. This figure includes currently held common stock plus various restricted stock and restricted stock unit awards that are scheduled to vest over time, subject to continued employment and, in some cases, achievement of performance goals.

What future vesting equity awards does Kumar have at Astrana Health (ASTH)?

Kumar’s holdings include 28,378 restricted shares vesting on January 23, 2027, and additional restricted shares and units tied to performance goals. He also holds 20,027 restricted stock units that will vest in six equal semi-annual installments beginning on September 5, 2026, subject to continued employment.

What is the purpose of the Form 4 tax-withholding transaction at Astrana Health (ASTH)?

The Form 4 shows shares surrendered to cover tax withholding from vested restricted stock units. Instead of paying taxes in cash, Kumar used 1,697 company shares valued at $25.07 each, a common administrative mechanism for handling tax liabilities on equity compensation awards.

Do Kumar’s Astrana Health (ASTH) holdings include shares from an employee stock purchase plan?

Yes. The footnotes state his total includes 1,405 shares acquired under Astrana Health’s Employee Stock Purchase Plan. These shares are part of his overall 200,335-share direct holding, alongside time-based and performance-based restricted stock and restricted stock units scheduled to vest in the future.